KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueDividends payablesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetMinority InterestOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Health Investors (NHI) Common Equity: 2009-2025

Historic Common Equity for National Health Investors (NHI) over the last 14 years, with Jun 2025 value amounting to $1.5 billion.

  • National Health Investors' Common Equity rose 18.63% to $1.5 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $1.5 billion, marking a year-over-year increase of 18.63%. This contributed to the annual value of $1.4 billion for FY2024, which is 8.78% up from last year.
  • Latest data reveals that National Health Investors reported Common Equity of $1.5 billion as of Q2 2025, which was up 3.69% from $1.4 billion recorded in Q1 2025.
  • National Health Investors' 5-year Common Equity high stood at $1.6 billion for Q1 2021, and its period low was $1.2 billion during Q3 2024.
  • Moreover, its 3-year median value for Common Equity was $1.3 billion (2023), whereas its average is $1.3 billion.
  • Per our database at Business Quant, National Health Investors' Common Equity fell by 15.09% in 2022 and then climbed by 18.63% in 2025.
  • Quarterly analysis of 5 years shows National Health Investors' Common Equity stood at $1.5 billion in 2021, then declined by 15.09% to $1.3 billion in 2022, then decreased by 3.39% to $1.3 billion in 2023, then fell by 2.55% to $1.2 billion in 2024, then climbed by 18.63% to $1.5 billion in 2025.
  • Its Common Equity was $1.5 billion in Q2 2025, compared to $1.4 billion in Q1 2025 and $1.2 billion in Q3 2024.